Raise $10M+ With This Disease‑Agnostic Therapeutics Pitch Deck Template

Last Updated:

Photo of author

Viktor

Institutional Capital & Decision-Ready Pitch Advisor. Helping founders, funds, and operators structure pitches that survive institutional evaluation.

Let’s cut to the chase: you’ve developed a therapeutic platform—or small molecule modality—that isn’t limited to one disease—it can pivot across oncology, neurology, inflammation—or more. But when you pitch, something stalls. It isn’t the science—it’s how the story appears.

I’m Viktor, a pitch deck consultant and a creative business strategist. Over the past 13 years, I’ve helped businesses secure millions of $ in funding thanks to my approach and I’m sharing it here in this pitch deck guide.

This template isn’t hypothetical. It’s built on pitch decks that already helped raise capital for disease‑agnostic platforms. Slide by slide, you’ll learn how to craft your elevator pitch, define the market, explain the disease‑agnostic advantage, show your solution, lay out the competitive landscape, and present a clear ask—all in an order investors understand and trust.

If you’re positioning a versatile therapeutic platform—and want to communicate depth + breadth while raising serious capital—this gives you a structure that speaks investor language, not just scientific language.

Get My 12 Slide Framework That Got $500mil in Funding For Clients.

What do you think of having 12 dead simple formulas, that will help you craft 12 slides, in about 1 hour? That’s what you’ll get, when you download my 12 slide framework. Save hours crafting your pitch deck copy with my tested approach that includes:

  • Elevator pitch one sentence formula
  • Problem/ solution slide one sentence formula
  • Competitor slide one sentence formula
  • 9 other formulas, tips, tricks and advice

The formulas worked for 40+ industries and 500+ companies. Including the one you’re looking at now.

Get it On Gumroad
Get It On Patreon

Clicking the link won’t charge you anything.

“The amount of know-how Viktor has about the industry is astounding. No wonder he can build a pitch deck for just about any product or service; completely hands-off.”

★★★★★

Fresh Case Study: Check out how we helped Harmon build a pitch deck for their hormonal therapy platform, and how Scarcell Therapeutics got an investor ready pitch deck for their cell therapy treatment method.

12 Slide Disease Agnostic Pitch Deck Template

The above is is just a simplified template.

Founders that are serious about getting the funding they need, opt in for a deck has industry specific content, superb narrative and award winning design like these ones below:

I can help you build that deck with my hands-off process in 7 days or less.

Book a free 30 minute call below if you’re serious about getting an investor ready deck, and we’ll discuss your needs in detail. I’ll help you design the deck, write the content, develop the narrative and flesh out the strategy with financials.

Book the free call
★★★★★

Follow us on social for the newest templates:

1. Elevator Pitch Slide

Slide Title: Revolutionizing Therapeutics with Disease-Agnostic Small Molecules

Content: Our innovative small molecule modality provides a versatile and cost-effective therapeutic solution, capable of targeting a wide range of diseases with high precision. Imagine a treatment as adaptable as a Swiss Army knife, efficiently addressing various medical conditions and drastically improving patient outcomes.

Visuals:

  • Image of a Swiss Army knife morphing into a pill, symbolizing versatility.
  • Tagline: “One Solution, Many Diseases.”

2. Market Opportunity

Slide Title: A Billion-Dollar Market for Versatile Therapeutics

Content:

  • Global Market Size: The global small molecule drug market is currently valued at over $160 billion, with a projected CAGR of 5.5%.
  • Unmet Needs: There are significant gaps in treatment efficacy and accessibility across various disease areas, including oncology, infectious diseases, and neurological disorders.
  • Growth Potential: Our technology is positioned to capture a substantial share of this expanding market by offering a flexible and scalable solution.

Visuals:

  • Graph showing market size growth from $160 billion to projected future values.
  • Infographic highlighting key unmet needs in oncology, infectious diseases, and neurological disorders.

3. Target Market

Slide Title: Target Market Analysis: Broad Yet Focused

Content:

  • Total Addressable Market (TAM): Entire global pharmaceutical market focused on small molecule drugs.
  • Serviceable Available Market (SAM): Diseases with unmet medical needs or inadequate treatments, such as rare genetic disorders and multi-drug resistant infections.
  • Serviceable Obtainable Market (SOM): Initial focus on oncology and infectious diseases due to high demand and fewer effective treatments.

Visuals:

  • Venn diagram showing TAM, SAM, and SOM with overlapping areas.
  • Market size estimates for each segment.

4. Problem and Impact

Slide Title: Critical Problems Demand Versatile Solutions

Content: Problems:

  1. Limited Efficacy: Current treatments often lack effectiveness across various diseases.
  2. High Costs: Existing therapies are expensive, limiting accessibility.
  3. High Failure Rates: Drug development processes are inefficient, with high rates of failure.

Impact if Unresolved:

  1. Patient Suffering: Patients face prolonged suffering due to ineffective treatments.
  2. Economic Burden: Increased healthcare costs strain both patients and healthcare systems.
  3. Slower Innovation: Inefficiencies slow down the pace of medical advancements.

Visuals:

  • Icons representing limited efficacy, high costs, and high failure rates.
  • Image of a frustrated patient and a stressed healthcare professional.

Hold on. You might want to check my list on the best presentation and communication books...

These are crucial books that will help you improve the design and structure of your decks and presentations, besides improving your delivery and skyrocketing your confidence when facing investors. Check them out below.

10 Best Presentation Books
26 Best Communication Books

5. The Opportunity/Gap

Slide Title: The Market Gap: A Clear Path for Innovation

Content:

  • Existing Gap: There is a significant need for versatile, cost-effective therapeutic solutions that can address multiple diseases.
  • Market Demand: High demand for treatments that can adapt to various conditions, providing a competitive advantage.
  • Our Position: Positioned to fill this gap with our disease-agnostic small molecule modality, offering high precision and broad applicability.

Visuals:

  • Gap analysis chart showing current market gaps and our solution’s fit.
  • Image of a puzzle piece fitting perfectly into a gap.

6. Unique Solution

Slide Title: Our Unique Solution: The Future of Therapeutics

Content: Technology & Uniqueness:

  • High Specificity: Our small molecules are designed for high precision in targeting disease mechanisms.
  • Broad Applicability: Capable of treating a wide range of diseases, making it a universal therapeutic solution.
  • Cost-Effective Production: Efficient manufacturing processes reduce costs and enhance scalability.

Benefits:

  • Patients: Improved access to effective treatments.
  • Healthcare Providers: Broader treatment options with lower risk of adverse effects.
  • Pharmaceutical Companies: Streamlined drug development and reduced R&D costs.

Visuals:

  • Diagram of the technology highlighting high specificity and broad applicability.
  • Comparative chart showing cost-effectiveness against traditional therapies.

7. Customer Benefits

Slide Title: Comprehensive Benefits Across the Healthcare Ecosystem

Content: For Patients:

  • Increased Access: Affordable and effective treatments available for a wide range of conditions.
  • Improved Outcomes: Higher precision leads to better health outcomes and quality of life.

For Healthcare Providers:

  • Broader Treatment Options: Ability to treat multiple diseases with a single therapeutic approach.
  • Reduced Side Effects: High specificity minimizes adverse effects.

For Payers:

  • Cost Savings: Lower overall treatment costs due to more effective therapies and reduced complications.
  • Value-Based Care: Supports initiatives focused on cost-effective healthcare solutions.

For Pharmaceutical Companies:

  • Streamlined R&D: More efficient drug development processes.
  • Market Advantage: Unique positioning in a competitive market.

Visuals:

  • Icons representing patients, healthcare providers, payers, and pharmaceutical companies.
  • Infographic showing benefits for each stakeholder group.

8. How It Works and Plain Vanilla

Slide Title: How It Works: Simple, Effective, and Compatible

Content: How It Works:

  1. Research: Identification of small molecules with broad-spectrum activity.
  2. Development: Optimization for high efficacy and safety across multiple diseases.
  3. Deployment: Clinical trials and market launch.

Plain Vanilla:

  • Compatibility: Aligns with existing pharmaceutical manufacturing processes, ensuring minimal disruption.
  • Scalability: Easily scalable to meet market demands.
  • Integration: Seamlessly integrates with current healthcare systems and practices.

Visuals:

  • Flowchart showing the research, development, and deployment process.
  • Diagram illustrating alignment with existing technologies.

9. Competitor Analysis

Slide Title: Competitive Landscape: Standing Out in the Market

Content: Competitors:

  1. Traditional Pharmaceuticals: Focus on disease-specific treatments.
  2. Biologics and Gene Therapies: High costs and complexity.

Our Unique Positioning:

  • Versatility: Ability to treat multiple diseases with a single molecule.
  • Cost-Effectiveness: Lower production costs and faster time to market.
  • High Specificity: Reduced side effects compared to traditional treatments.

Visuals:

  • Competitive matrix showing our advantages in versatility, cost-effectiveness, and specificity.
  • Graph comparing market positioning of key competitors.

10. Case Studies and Pilot Projects

Slide Title: Proven Success: Case Studies and Pilot Projects

Content: Oncology:

  • Case Study 1: Demonstrated efficacy in targeting multiple cancer types, reducing tumor growth by 70% in pre-clinical trials.

Infectious Diseases:

  • Case Study 2: Effective against a broad spectrum of multi-drug resistant infections, showing a 90% success rate in initial clinical trials.

Pilot Projects:

  • Project 1: Collaboration with leading cancer research institutions to further validate our solution.
  • Project 2: Partnership with infectious disease clinics for real-world testing and feedback.

Visuals:

  • Graphs showing results from pre-clinical and clinical trials.
  • Images of collaborative research efforts and partnerships.

11. Timeline

Slide Title: Roadmap to Success: Our Implementation Timeline

Content: Year 1-2:

  • Research and Development: Intensive R&D and initial clinical trials.
  • Milestones: Achieve proof of concept and secure initial regulatory approvals.

Year 3-4:

  • Advanced Clinical Trials: Conduct Phase II and III clinical trials.
  • Milestones: Obtain regulatory approvals and prepare for market launch.

Year 5:

  • Market Launch and Scaling: Launch products in key markets and scale production.
  • Milestones: Achieve significant market penetration and revenue growth.

Visuals:

  • Timeline graphic showing key milestones and phases.
  • Icons representing each stage of development.

12. Why Now

Slide Title: Why Now: The Urgency and Opportunity

Content: Current Need:

  • Rising Disease Incidence: Increasing prevalence of complex diseases requiring versatile solutions.
  • Demand for Cost-Effective Treatments: Healthcare systems under pressure to reduce costs while improving outcomes.

Technological Advancements:

  • Innovative Research Tools: Advances in small molecule research and technology enabling rapid development.
  • Regulatory Support: Growing support from regulatory bodies for innovative, cost-effective treatments.

Market Readiness:

  • Healthcare Trends: Shift towards personalized and precision medicine.
  • Investment Climate: Strong investor interest in biotech innovations.

Visuals:

  • Infographic showing rising disease incidence and healthcare costs.
  • Graph showing technological advancements and market readiness.

Pick a specific pitch deck design from the award winning Envato.

1000’s of ready made Powerpoint, Google Slides, and Keynote presentations that are easy to edit, format and tailor to your idea.

Grab The Deal And Build Your Deck

Last Words

You now hold a 12‑slide blueprint designed for disease‑agnostic therapeutic ventures—one grounded in decks that delivered real funding.

If this aligns with your project, adapt it, refine it, and pitch with confidence. And if your platform has unique features—different modalities, regulatory strategies, or market segments—reach out. I’ll help tailor the deck so it fits your vision, strengthens your narrative, and maximizes your chances of raising capital.

Get an investor ready pitch deck that gets you funded and saves over 30 hours of your time.

Join 100s of successful entrepreneurs who’ve transformed their pitch decks by using my hands-off approach, which includes: market research, copy, design, financials, narrative and strategy.

1 week turnaround time and less. Special pricing for early stage companies.

Start Winning Investors. Book The Free Exploratory Call.

The least you will get on this call is 10 actionable tips & strategies to own that next pitch, worth $599, for free.

top-rated-pitch-deck-expert-on-upwork-viktor-ilijev

If you want to really dive into the world of pitch decks, check out our complete collection of pitch deck templates.

Related Biotech Pitch Deck Templates

Looking for a step by step guide to build a Biotech pitch deck?

Check out our in-depth biotech pitch deck guide.

Related Medical Pitch Deck Templates

Check out our massive directory of pitch deck templates, or the following related templates:

Looking for a step by step guide to build a medical pitch deck?

Check out our in-depth medical pitch deck guide.

Check out some of the essential 101 guides:

Pitching clarity for capital decisions.

Twitter Youtube Instagram Linkedin X-twitter Pinterest Tiktok Dribbble Behance

Hire me through Upwork.

Locations
Office 1: 633 North Wells Street Chicago, IL, United States, 60654
HQ: Boulevard P.O. 10000 Skopje, North Macedonia

Institutional Capital Logic

Sector Capital Evaluation

Pitch Deck Evidence

Latest News

Mechanics

Latest Frameworks

Services

Industry Specific Services:

Table of contents